News | August 30, 2023
Novo Nordisk, Eli Lilly record growth in Q2 driven by obesity, diabetes drug sales
Novo Nordisk’s GLP-1 Ozempic has reported a YoY increase in revenue from $2.1 billion to $3.2 billion
Novo Nordisk’s GLP-1 Ozempic has reported a YoY increase in revenue from $2.1 billion to $3.2 billion
Aims to build the largest connected healthcare ecosystem in India
Guaifenesin extended-release tablets help to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder
The medical device sector is considered as one of the sunrise sectors in the country
DKSH has further fortified its strategic partnership with Biolin Scientific, a globally recognized pioneer in surface science instrumentation, across nine key markets in the APAC region
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Subscribe To Our Newsletter & Stay Updated
